Levetiracetam-induced torsades de pointes: An anomalous status

Key Result

Levetiracetam can induce torsades de pointes (TDP), evidenced by a 59-year-old female requiring multiple cardioversions after its administration.

Key Points

• The aim is to report a rare instance of torsades de pointes related to levetiracetam use.
• Documented a case involving a 59-year-old female patient.
• Monitored the patient's cardiac rhythm following levetiracetam administration.
• Treated multiple episodes of torsades de pointes with electric cardioversions.
• Observed multiple instances of torsades de pointes post-levetiracetam therapy.
• Noted that this is among the few documented cases worldwide.
• Findings highlight a previously underestimated cardiac risk associated with levetiracetam.